OPTI-FREE PUREMOIST OPTI-FREE PUREMOIST 2x10ozRecalls & reported problems
Alcon Laboratories, Inc. · Opti-Free Pure Moist Multi-Purpose Disinfecting Solution Twin Pack 2 x 10 ozhttps://gudid.fda.gov/gudid/app/admin/udi/recordDetails.xhtml# · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00300650361057), received between Jan 12, 2026 and Jan 12, 2026 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Burning Sensation1
- Eye Irritation1
- Eye Pain1
- Keratitis1
- Photophobia1
- Red Eye(s)1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJan 12, 2026Adverse Event Without Identified Device or Use Problem
AS INITIALLY REPORTED BY CONSUMER STATING THAT THE CONSUMER STARTED EXPERIENCED BURNING, EYE PAIN APPROXIMATELY TWO WEEKS BEFORE CONSUMER WENT TO PRIMARY CARE PROVIDER AS WELL AS EYE DOCTOR, AT FIRST, THEY THOUGHT THAT IT WAS DUE TO CONTACT LENS, AS IT WAS APPROACHING THE ONE-MONTH TIME FRAME AND USED NEW CONTACTS WITH NO IMPROVEMENT. THE INFECTION WAS SO SEVERE THAT THE CONSUMER HAD EXTREME LIGHT SENSITIVITY AND MIGRAINES. THE CONSUMER SOUGHT MEDICAL INTERVENTION AND DIAGNOSED WITH KERATITIS. THE CONSUMER WAS PRESCRIBED WITH UNSPECIFIED STEROID EYE DROPS. THE CURRENT STATUS OF THE CONSUMER¿S EYE WAS SYMPTOMS IMPROVING AT THE TIME OF THIS REPORT. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT NOT YET RECEIVED. ADDITIONAL INFORMATION RECEIVED STATING THAT CONSUMER ALSO EXPERIENCED RED EYE, TWO WEEKS AFTER DOCTOR VISIT AND TREATMENT WITH STEROID EYE DROP THE CONSUMER TRIED TO WEAR A BRAND-NEW PAIR OF CONTACTS WHICH WENT WELL THE FIRST DAY, HOWEVER AFTER SOAKING OVERNIGHT IN THE SOLUTION THE CONSUMER'S EYE WAS IRRITATED. THE CONSUMER STOPPED USING THE SOLUTION. AFTER CHANGING THE SOLUTION, THE CONSUMER WAS ABLE TO WEAR CONTACTS BUT NOT FOR A FULL DAY AS BEFORE. THE CURRENT STATUS OF TH
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Burning Sensation; Eye Irritation; Eye Pain; Keratitis; Photophobia; Red Eye(s)
MAUDE report 24034053 ↗
Other Accessories, soft lens products devices
- OPTI-FREE REPLENISH OPTI-FREE REPLENISH 10ozAlcon Laboratories, Inc. · Accessories, soft lens products1 recall1 report
- Clear Care Clear Care 12ozAlcon Laboratories, Inc. · Accessories, soft lens products1 recall0 reports
- OPTI-FREE REPLENISH OPTI-FREE REPLENISH 2ozAlcon Laboratories, Inc. · Accessories, soft lens products1 recall0 reports
- OPTI-FREE REPLENISH OPTI-FREE REPLENISH 4ozAlcon Laboratories, Inc. · Accessories, soft lens products1 recall0 reports
- REFRESH CONTACTS® Contact Lens Comfort Drops 91822USAllergan, Inc. · Accessories, Soft Lens Products1 recall0 reports
- Clear Care Clear Care 2x12ozAlcon Laboratories, Inc. · Accessories, soft lens products4 reports
- Clear Care Clear Care 2x12ozAlcon Laboratories, Inc. · Accessories, soft lens products4 reports
- COMPLETE 93504LCAHZJohnson & Johnson Surgical Vision, Inc. · Accessories, soft lens products4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page